Results 231 to 240 of about 38,609 (257)
Some of the next articles are maybe not open access.

Lovastatin: Extended-Interval (Alternate-Day) Dosing

Hospital Pharmacy, 2001
Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses.
Joyce Generali, Dennis J. Cada
openaire   +1 more source

Extended-interval dosing of aminoglycosides.

The Mount Sinai journal of medicine, New York, 1998
Aminoglycosides are efficacious agents. Their use has declined partly because of the development of newer, presumably less toxic agents. Research shows that aminoglycosides can be dosed differently than in the past, maintaining efficacy while reducing aminoglycoside toxicities. Aminoglycosides administered with newer agents may help overcome antibiotic
M E, Blam, G S, Hammer
openaire   +1 more source

Extended-Interval Aminoglycoside Dosing for Treatment of Enterococcal and Staphylococcal Osteomyelitis

Annals of Pharmacotherapy, 2004
BACKGROUND: Gram-positive osteomyelitis requires long-term antibiotic therapy, much of which is often administered in the outpatient setting. Historically, synergistic aminoglycoside use in these infections requires multiple daily doses, which can be inconvenient.
A Christie, Graham   +3 more
openaire   +2 more sources

Two nomograms for determining extended-dosing intervals for gentamicin in neonates

American Journal of Health-System Pharmacy, 2008
The development of two nomograms to predict dosing intervals for gentamicin in neonates based on one gentamicin concentration is described.Pooled data from three retrospective studies on neonates age seven days or younger were used to create nomograms that would predict dosing intervals for gentamicin.
John E, Murphy, Anthony M, Roether
openaire   +2 more sources

Extended-interval dosing of natalizumab in NOVA

The Lancet Neurology, 2023
Olaf, Stüve, Bastian, Tugemann
openaire   +2 more sources

Extended-Interval dosing of tobramycin in neonates: Implications for therapeutic drug monitoring

Clinical Pharmacology & Therapeutics, 2002
Our objective was to individualize tobramycin dosing regimens in neonates of various gestational ages with use of early therapeutic drug monitoring.This study was performed in neonatal patients with suspected septicemia in the first week of life. All patients received tobramycin, 4 mg/kg per dose, as a 30-minute intravenous infusion, with a gestational
de Hoog, Matthijs   +4 more
openaire   +2 more sources

Extended interval gentamicin dosing in obstetrics

American Journal of Obstetrics and Gynecology, 2023
Li C, Hardy E, Moreno K
openaire   +1 more source

Extended-interval dosing of natalizumab in NOVA – Authors' reply

The Lancet Neurology, 2023
John F, Foley   +2 more
openaire   +2 more sources

Potential for extending the chloramphenicol dosing interval for canine urinary tract infections

Journal of Veterinary Pharmacology and Therapeutics
AbstractCanine urinary excretion of chloramphenicol was evaluated to optimize a dosing protocol for treating urinary tract infections. Seven healthy male intact purpose‐bred Beagles and six healthy client‐owned dogs of various breeds each received a single oral 50 mg/kg dose of chloramphenicol.
Kate S. KuKanich   +3 more
openaire   +2 more sources

Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine

Pediatrics
BACKGROUNDNine-valent human papillomavirus (9vHPV) vaccines can be administered in 2 doses 6 to 12 months apart in adolescents. The impact of extended dose intervals is unknown. We report immunogenicity and safety data in adolescents of a second 9vHPV vaccine dose administered ≥1 year after the first.METHODSThis open-label safety and immunogenicity ...
Nicola P, Klein   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy